JPRN-UMIN000000769
Completed
Phase 1
Assessment of efficacy and safety of immunotherapy for unresectable locally advanced pancreatic cancer. - Immunotherapy for pancreatic cancer.
agoya University Hospital0 sites15 target enrollmentSeptember 1, 2007
Conditionspancreatic ductal carcinoma
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- pancreatic ductal carcinoma
- Sponsor
- agoya University Hospital
- Enrollment
- 15
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with immunologic abnormalities
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 4
Assessment of the protection offered by single dose of COVID-19 vaccines in individuals previously affected with COVID-19CTRI/2021/10/037099Indian Council of Medical research ICMR
Completed
Phase 3
Sub lingual immunotherapy of Nasal allergiesPerennial allergic rhinitis.Other allergic rhinitisIRCT2017042323235N9Vice chancellor for research, Mashhad University of Medical Sciences40
Recruiting
Phase 2
Efficacy stem cells in improving the symptoms of patients with lupusIRCT20130812014333N182Kermanshah University of Medical Sciences20
Unknown
Phase 3
A clinical trial to study immunogenicity and safety of Purified Chick Embryo Cell Culture Rabies Vaccine administered intradermallyHealth Condition 1: Z23- Encounter for immunizationCTRI/2010/091/000509Cadila Healthcare Ltd36
Completed
Phase 4
Protection and Safety of rabies vaccine when administered intradermallyCTRI/2012/06/002720I70